These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 17704361

  • 21. Vision specific quality of life in children with optic pathway gliomas.
    Avery RA, Hardy KK.
    J Neurooncol; 2014 Jan; 116(2):341-7. PubMed ID: 24197987
    [Abstract] [Full Text] [Related]

  • 22. The role of surgery in optic pathway/hypothalamic gliomas in children.
    Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C.
    J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
    [Abstract] [Full Text] [Related]

  • 23. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
    Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, Simmons I, Ferner R, Grill J, Hargrave D, Driever PH, Evans DG, Opocher E, SIOPE NF1 OPG Nottingham, UK, Workshop 2014.
    Neuro Oncol; 2021 Jan 30; 23(1):100-111. PubMed ID: 32628746
    [Abstract] [Full Text] [Related]

  • 24. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.
    Invest Ophthalmol Vis Sci; 2007 Jun 30; 48(6):2895-902. PubMed ID: 17525226
    [Abstract] [Full Text] [Related]

  • 25. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S, Birch JM, Kerr B, Lashford L, Evans DG.
    Arch Dis Child; 2002 Jul 30; 87(1):65-70. PubMed ID: 12089128
    [Abstract] [Full Text] [Related]

  • 26. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    Rakotonjanahary J, Gravier N, Lambron J, De Carli E, Toulgoat F, Delion M, Pellier I, Rialland X.
    PLoS One; 2019 Jul 30; 14(3):e0212107. PubMed ID: 30849081
    [Abstract] [Full Text] [Related]

  • 27. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J, Schüttauf F, Salamon JM, Kordes U, Friedrich RE, Mautner VF.
    Anticancer Res; 2019 Feb 30; 39(2):827-831. PubMed ID: 30711963
    [Abstract] [Full Text] [Related]

  • 28. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K, Daniels DJ, Spoudeas H, Phipps K, Gan HW, Boop FA.
    Childs Nerv Syst; 2015 Nov 30; 31(11):2041-9. PubMed ID: 26277358
    [Abstract] [Full Text] [Related]

  • 29. Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.
    Mitchell AE, Elder JE, Mackey DA, Waters KD, Ashley DM.
    J Pediatr Hematol Oncol; 2001 Dec 30; 23(9):572-7. PubMed ID: 11902299
    [Abstract] [Full Text] [Related]

  • 30. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
    Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG.
    J Clin Oncol; 2006 Jun 01; 24(16):2570-5. PubMed ID: 16735710
    [Abstract] [Full Text] [Related]

  • 31. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology.
    Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C, French Society of Pediatric Oncology.
    J Clin Oncol; 2003 Dec 15; 21(24):4572-8. PubMed ID: 14673044
    [Abstract] [Full Text] [Related]

  • 32. Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
    Kotch C, Avery R, Getz KD, Bouffet E, de Blank P, Listernick R, Gutmann DH, Bornhorst M, Campen C, Liu GT, Aplenc R, Li Y, Fisher MJ.
    Neuro Oncol; 2022 Aug 01; 24(8):1377-1386. PubMed ID: 35018469
    [Abstract] [Full Text] [Related]

  • 33. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M.
    J Neurooncol; 2017 Sep 01; 134(2):279-287. PubMed ID: 28577031
    [Abstract] [Full Text] [Related]

  • 34. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Ater JL, Xia C, Mazewski CM, Booth TN, Freyer DR, Packer RJ, Sposto R, Vezina G, Pollack IF.
    Cancer; 2016 Jun 15; 122(12):1928-36. PubMed ID: 27061921
    [Abstract] [Full Text] [Related]

  • 35. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH, Larson SA, Creel D, Hoffman R.
    J AAPOS; 2006 Aug 15; 10(4):307-11. PubMed ID: 16935228
    [Abstract] [Full Text] [Related]

  • 36. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ.
    Br J Ophthalmol; 2016 Apr 15; 100(4):510-4. PubMed ID: 26294105
    [Abstract] [Full Text] [Related]

  • 37. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK, Kaatsch P, Kortmann R, Wiestler OD.
    Klin Padiatr; 2000 Apr 15; 212(4):177-84. PubMed ID: 10994547
    [Abstract] [Full Text] [Related]

  • 38. A novel mutation in the NF1 gene in two siblings with neurofibromatosis type 1 and bilateral optic pathway glioma.
    Kebudi R, Tuncer S, Upadhyaya M, Peksayar G, Spurlock G, Yazici H.
    Pediatr Blood Cancer; 2008 Mar 15; 50(3):713-5. PubMed ID: 17514731
    [Abstract] [Full Text] [Related]

  • 39. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review.
    Cardellicchio S, Bacci G, Farina S, Genitori L, Massimino M, de Martino M, Caputo R, Sardi I.
    Neuropediatrics; 2014 Feb 15; 45(1):42-9. PubMed ID: 24272769
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.